Carmichael Hill & Associates, Inc. Amgen Inc Transaction History

Carmichael Hill & Associates, Inc.

$279 Million
Q3 2024

A detailed history of Carmichael Hill & Associates, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Carmichael Hill & Associates, Inc. holds 693 shares of AMGN stock, worth $196,028. This represents 0.08% of its overall portfolio holdings.

Number of Shares

693

Previous 602 15.12%

Holding current value

$196,028

Previous $188,000 18.62%

% of portfolio

0.08%

Previous 0.07%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$309.38 - $337.38 $28,153 - $30,701	91 Added 15.12%	693 $223,000
Q2 2024 Aug 02, 2024	SELL	$262.75 - $319.31 $53,075 - $64,500	-202 Reduced 25.12%	602 $188,000
Q1 2024 Apr 24, 2024	SELL	$268.87 - $324.56 $17,207 - $20,771	-64 Reduced 7.37%	804 $228,000
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $22,670 - $25,568	-101 Reduced 10.42%	868 $196,000
Q2 2022 Aug 05, 2022	SELL	$230.71 - $256.74 $12,458 - $13,863	-54 Reduced 5.28%	969 $236,000
Q4 2021 Jan 31, 2022	SELL	$198.88 - $227.6 $8,949 - $10,242	-45 Reduced 4.21%	1,023 $230,000
Q2 2021 Aug 03, 2021	SELL	$233.58 - $259.14 $467 - $518	-2 Reduced 0.19%	1,068 $260,000
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $15,721 - $17,483	67 Added 6.68%	1,070 $272,000
Q4 2019 Jan 30, 2020	SELL	$189.21 - $243.2 $15,704 - $20,185	-83 Reduced 7.64%	1,003 $242,000
Q3 2019 Nov 06, 2019	SELL	$174.11 - $208.62 $40,915 - $49,025	-235 Reduced 17.79%	1,086 $210,000
Q2 2019 Jul 30, 2019	SELL	$166.7 - $195.41 $8,835 - $10,356	-53 Reduced 3.86%	1,321 $243,000
Q1 2019 Apr 23, 2019	BUY	$180.87 - $203.88 $361 - $407	2 Added 0.15%	1,374 $261,000
Q4 2018 Jan 16, 2019	SELL	$178.4 - $208.25 $13,201 - $15,410	-74 Reduced 5.12%	1,372 $267,000
Q2 2018 Aug 01, 2018	BUY	$166.05 - $186.51 $166 - $186	1 Added 0.07%	1,446 $267,000
Q1 2018 Apr 27, 2018	SELL	$169.43 - $198.0 $4,913 - $5,742	-29 Reduced 1.97%	1,445 $246,000
Q4 2017 Feb 07, 2018	BUY	$168.79 - $188.59 $248,796 - $277,981	1,474	1,474 $256,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $151B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carmichael Hill & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Carmichael Hill & Associates, Inc. with notifications on news.

Account

Carmichael Hill & Associates, Inc. Amgen Inc Transaction History